Log inSign up

SalioGen Therapeutics

1 follower

‌

SalioGen Therapeutics is advancing the Exact DNA Integration Technology (EDIT) platform, the only genome engineering technology that is mammal-derived, for use in potentially curative non-viral gene therapy.

Industries

Education, Biotechnology

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Jason F. Cole
CEO & Chairman

Jason F. Cole

Collapse
Will Mcgown
Executive Director, Finance & FP&A
Jill Murray
VP, Human Resources
Joseph J. Higgins
President & Chief Scientific Officer
Jeff Kopacz
SVP of Intellectual Property & Contracts
Joe Senn
SVP & Head of R&D
Jill Murray, PHR
Vice President Human Resources
Oleg Iartchouk
Vice President, Biomarkers And Genomics
William McGowan
Executive Director, Finance And Fp&a
Subhro Guhathakurta
Executive Director, Platform Development & Genetic Engineering
SJ
Sujit Jain
Sr Director, CMC Operations
LauraLee Hughes
Director, Corporate Development & Strategy
QB
Quinner Baltazar
Associate Director
Pat Sacco
SVP of Manufacturing, Quality & Operations
Sandeep Nema
SVP, Technical Operations

Teams

BD
+11

Scientific Advisory and Development

14 members

+4

Scientific Research

7 members

+3

Leadership Team

6 members

Similar companies

Kura Oncology

17 followers

Senti Biosciences

1 follower

SpringWorks Therapeutics

5 followers

REVOLUTION Medicines

5 followers

Immunovant

5 followers

C4 Therapeutics

3 followers

Precigen

3 followers

Pivot Bio

2 followers

Relay Therapeutics

1 follower

CHDI Foundation

5 followers

SOPHiA GENETICS

4 followers

Explore companies